To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy Adults
Clinical trial NCT05805826 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05805826
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-23
- Primary completion
- 2031-06-19
- Enrollment
- 936
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.